These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23025256)

  • 1. Functional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective study.
    Hellgren KJ; Bengtsson B; Agardh E
    Acta Ophthalmol; 2013 Nov; 91(7):672-7. PubMed ID: 23025256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study.
    Hellgren KJ; Agardh E; Bengtsson B
    Diabetes; 2014 Sep; 63(9):3104-11. PubMed ID: 24848062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of focal/grid laser treatment on the central visual field in diabetic macular oedema: a 2-year follow-up study.
    Tababat-Khani P; Bengtsson B; Agardh E
    Acta Ophthalmol; 2016 May; 94(3):240-5. PubMed ID: 26806322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorganization of Retinal Inner Layers (DRIL) and Neuroretinal Dysfunction in Early Diabetic Retinopathy.
    Joltikov KA; Sesi CA; de Castro VM; Davila JR; Anand R; Khan SM; Farbman N; Jackson GR; Johnson CA; Gardner TW
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5481-5486. PubMed ID: 30452602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivity.
    Hatef E; Hanout M; Moradi A; Colantuoni E; Bittencourt M; Liu H; Sepah YJ; Ibrahim M; Do DV; Guyton DL; Nguyen QD
    Eye (Lond); 2014 Oct; 28(10):1239-45. PubMed ID: 25104744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Multispot Laser Panretinal Photocoagulation on Retinal Sensitivity and Driving Eligibility in Patients With Diabetic Retinopathy.
    Subash M; Comyn O; Samy A; Qatarneh D; Antonakis S; Mehat M; Tee J; Mansour T; Xing W; Bunce C; Viswanathan A; Rubin G; Weleber R; Peto T; Wickham L; Michaelides M
    JAMA Ophthalmol; 2016 Jun; 134(6):666-72. PubMed ID: 27077924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Macular Ischemia: Influence of Optical Coherence Tomography Angiography Parameters on Changes in Functional Outcomes Over One Year.
    Tsai ASH; Jordan-Yu JM; Gan ATL; Teo KYC; Tan GSW; Lee SY; Chong V; Cheung CMG
    Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):9. PubMed ID: 33404598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    ; Fong DS; Strauber SF; Aiello LP; Beck RW; Callanan DG; Danis RP; Davis MD; Feman SS; Ferris F; Friedman SM; Garcia CA; Glassman AR; Han DP; Le D; Kollman C; Lauer AK; Recchia FM; Solomon SD
    Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual fields at different stages of diabetic retinopathy.
    Henricsson M; Heijl A
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):560-9. PubMed ID: 7887153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes.
    Sabeti F; Nolan CJ; James AC; Jenkins A; Maddess T
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4504-13. PubMed ID: 26200488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
    Scott IU; Jackson GR; Quillen DA; Klein R; Liao J; Gardner TW
    JAMA Ophthalmol; 2014 Sep; 132(9):1137-42. PubMed ID: 24969516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.
    Joltikov KA; de Castro VM; Davila JR; Anand R; Khan SM; Farbman N; Jackson GR; Johnson CA; Gardner TW
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO277-BIO290. PubMed ID: 28973314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
    Acta Ophthalmol; 2013 May; 91(3):251-8. PubMed ID: 22176513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
    Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
    Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
    Ribeiro L; Bandello F; Tejerina AN; Vujosevic S; Varano M; Egan C; Sivaprasad S; Menon G; Massin P; Verbraak FD; Lund-Andersen H; Martinez JP; Jürgens I; Smets E; Coriat C; Wiedemann P; Ágoas V; Querques G; Holz FG; Nunes S; Neves C; Cunha-Vaz J;
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5698-705. PubMed ID: 26322834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety.
    Vujosevic S; Martini F; Longhin E; Convento E; Cavarzeran F; Midena E
    Retina; 2015 Aug; 35(8):1594-603. PubMed ID: 25719988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual fields correlate better than visual acuity to severity of diabetic retinopathy.
    Bengtsson B; Heijl A; Agardh E
    Diabetologia; 2005 Dec; 48(12):2494-500. PubMed ID: 16261313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic macular edema: fundus autofluorescence and functional correlations.
    Vujosevic S; Casciano M; Pilotto E; Boccassini B; Varano M; Midena E
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):442-8. PubMed ID: 20720226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.